Skip to main content

CapForce Inc.

CFOR
Exchange
OTC
Industry
Services-Medical Laboratories
SEC CIK
0001293818

No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding CapForce Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of CFOR: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders1417+3
Shares321.9K293.8K−28.2K (−8.7%)
Value$121.5K$123.7K+$2.22K (+1.8%)

New holders (7)

Institutions that held CapForce Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CFOR in Q4 2023
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC66,000$28.0K0.00%
Virtu Financial LLC40,384$17.0K0.00%
Citadel Advisors LLC36,377$15.3K0.00%
Connective Capital Management, LLC25,000$10.5K0.01%
Two Sigma Securities, LLC12,102$5.08K0.00%
Qube Research & Technologies Ltd200$840.00%
BNP Paribas Arbitrage, SA1$00.00%

Sold out (4)

Institutions that held CapForce Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of CFOR in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Baader Bank INC171,110$61.1K
Boston Private Wealth LLC18,219$7.30K
Arete Wealth Advisors, LLC15,000$6.01K
Susquehanna International Group, LLP10,193$4.08K